Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?

por Jaramillo, Sonia, Schlenk, Richard F.
Publicado 2021

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question

por Jaramillo, Sonia, Schlenk, Richard F.
Publicado 2023

Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL

por Jaramillo, Sonia, Hennemann, Hannah, Horak, Peter, Teleanu, Veronica, Heilig, Christoph E., Hutter, Barbara, Stenzinger, Albrecht, Glimm, Hanno, Goeppert, Benjamin, Müller‐Tidow, Carsten, Fröhling, Stefan, Schönland, Stefan, Schlenk, Richard F.
Publicado 2020

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group

por Jaramillo, Sonia, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Döhner, Hartmut, Rosenquist, Richard, Ghia, Paolo, Stamatopoulos, Kostas, Stilgenbauer, Stephan
Publicado 2019

Validation of a proxy‐reported SARC‐F questionnaire for current and retrospective screening of sarcopenia‐related functional impairments

por Maurus, Johannes, Terzer, Tobias, Benner, Axel, Goisser, Sabine, Eidam, Annette, Roth, Anja, Janssen, Maike, Jaramillo, Sonia, Lorenz, Hannes Martin, Micol, William, Hauer, Klaus, Müller‐Tidow, Carsten, Bauer, Jürgen M., Jordan, Karin, Neuendorff, Nina Rosa
Publicado 2021

Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia

por Röhnert, Maximilian A., Kramer, Michael, Schadt, Jonas, Ensel, Philipp, Thiede, Christian, Krause, Stefan W., Bücklein, Veit, Hoffmann, Jörg, Jaramillo, Sonia, Schlenk, Richard F., Röllig, Christoph, Bornhäuser, Martin, McCarthy, Nicholas, Freeman, Sylvie, Oelschlägel, Uta, von Bonin, Malte
Publicado 2022

Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

por Jaramillo, Sonia, Le Cornet, Lucian, Kratzmann, Markus, Krisam, Johannes, Görner, Martin, Hänel, Mathias, Röllig, Christoph, Wass, Maxi, Scholl, Sebastian, Ringhoffer, Mark, Reichart, Alexander, Steffen, Björn, Kayser, Sabine, Mikesch, Jan-Henrik, Schaefer-Eckart, Kerstin, Schubert, Jörg, Geer, Thomas, Martin, Sonja, Kieser, Meinhard, Sauer, Tim, Kriegsmann, Katharina, Hundemer, Michael, Serve, Hubert, Bornhäuser, Martin, Müller-Tidow, Carsten, Schlenk, Richard F.
Publicado 2023

Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction ther...

por Jaramillo, Sonia, Krisam, Johannes, Le Cornet, Lucian, Kratzmann, Markus, Baumann, Lukas, Sauer, Tim, Crysandt, Martina, Rank, Andreas, Behringer, Dirk, Teichmann, Lino, Görner, Martin, Trappe, Ralf-Ulrich, Röllig, Christoph, Krause, Stefan, Hanoun, Maher, Hopfer, Olaf, Held, Gerhard, Buske, Sebastian, Fransecky, Lars, Kayser, Sabine, Schliemann, Christoph, Schaefer-Eckart, Kerstin, Al-Fareh, Yousef, Schubert, Jörg, Geer, Thomas, Kaufmann, Martin, Brecht, Arne, Niemann, Dirk, Kieser, Meinhard, Bornhäuser, Martin, Platzbecker, Uwe, Serve, Hubert, Baldus, Claudia D., Müller-Tidow, Carsten, Schlenk, Richard F.
Publicado 2021